Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al

Simon Francis Thomsen,1,2 Freja Lærke Sand1,2 1Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark; 2Department of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkWe read with interest the recent paper by Cooke et al about the use of biologic agents for in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thomsen SF, S, FL
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/191f30cb7bf14125b05761e9cfef3b22
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:191f30cb7bf14125b05761e9cfef3b22
record_format	dspace
spelling	oai:doaj.org-article:191f30cb7bf14125b05761e9cfef3b222021-12-02T01:29:23ZUse of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al1177-5491https://doaj.org/article/191f30cb7bf14125b05761e9cfef3b222015-11-01T00:00:00Zhttps://www.dovepress.com/use-of-anti-tnfs-for-difficult-to-treat-urticaria-response-to-cooke-et-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Simon Francis Thomsen,1,2 Freja Lærke Sand1,2 1Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark; 2Department of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkWe read with interest the recent paper by Cooke et al about the use of biologic agents for intractable urticaria.1 Particularly, the authors reckon that the evidence supporting the use of anti-TNFs is limited by the small numbers of patients in non-controlled studies, often with urticarial disorders not typical of chronic urticaria such as vasculitis and delayed pressure urticaria. However, we want to draw the authors’ and readers’ attention to our report from 2013 about the use of adalimumab and etanercept in 20 patients with chronic urticaria with or without angioedema2 (updated in 2015 with an additional five patients).3View original article by Cooke et al Thomsen SFSFLDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2015, Iss default, Pp 117-118 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Thomsen SF S FL Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
description	Simon Francis Thomsen,1,2 Freja Lærke Sand1,2 1Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark; 2Department of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkWe read with interest the recent paper by Cooke et al about the use of biologic agents for intractable urticaria.1 Particularly, the authors reckon that the evidence supporting the use of anti-TNFs is limited by the small numbers of patients in non-controlled studies, often with urticarial disorders not typical of chronic urticaria such as vasculitis and delayed pressure urticaria. However, we want to draw the authors’ and readers’ attention to our report from 2013 about the use of adalimumab and etanercept in 20 patients with chronic urticaria with or without angioedema2 (updated in 2015 with an additional five patients).3View original article by Cooke et al
format	article
author	Thomsen SF S FL
author_facet	Thomsen SF S FL
author_sort	Thomsen SF
title	Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
title_short	Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
title_full	Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
title_fullStr	Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
title_full_unstemmed	Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
title_sort	use of anti-tnfs for difficult-to-treat urticaria: response to cooke et al
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/191f30cb7bf14125b05761e9cfef3b22
work_keys_str_mv	AT thomsensf useofantitnfsfordifficulttotreaturticariaresponsetocookeetal AT s useofantitnfsfordifficulttotreaturticariaresponsetocookeetal AT fl useofantitnfsfordifficulttotreaturticariaresponsetocookeetal
_version_	1718403001559810048

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al

Ejemplares similares